Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Vaccines

Vaccines

Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the type of...

Vaccinations

Vaccinations

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

Vaccine Production

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...

Development of Immunocompetence

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...

Cancer Vaccines

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Choosing the Right Extracellular Vesicle: Cross-Kingdom Immunological Functions Linking Molecular Mechanisms to Therapeutic Applications.

Biomolecules·2026

Same author

Interplay Between TLR4 and Gelatinases in Tumour Growth and Metastasis.

Cells·2026

Same author

A non-conjugated peptide-adjuvant system of synthetic peptide-vaccine elicited potent antibody response and opsonic protection against clinical GAS strains.

Bioorganic chemistry·2026

Same author

Rational selection of antigenic targets for Group A Streptococcus vaccine: updates, challenges and opportunities.

NPJ vaccines·2026

Same author

Veterinary Forensic Pathology in the Investigation of Animal Cruelty: Post-Mortem Insights, Forensic Tools, Case Studies, and Legal Perspectives.

Animals : an open access journal from MDPI·2026

Same author

The Collaborative Collapse: Bile Acid Dysmetabolism as a Central Pathogenic Driver in Canine and Feline Multi-Systemic Disorders-From Mechanisms to Precision Therapeutics.

Veterinary sciences·2026

Search research articles

Related Experiment Video

Updated: May 15, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Modern subunit vaccines: development, components, and research opportunities.

Peter Michael Moyle¹, Istvan Toth

¹School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, QLD 4072, Australia. p.moyle@uq.edu.au

|January 15, 2013

Summary

Subunit vaccines offer improved safety and targeted development for diseases like HIV. Adjuvants and optimized delivery systems are crucial for enhancing immune responses and vaccine efficacy.

More Related Videos

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Related Experiment Videos

Last Updated: May 15, 2026

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Enrichment of Native and Recombinant Extracellular Vesicles of Mycobacteria

Published on: December 8, 2023

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development

Published on: March 16, 2022

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on: July 25, 2022

Area of Science:

Vaccinology
Immunology
Medicinal Chemistry

Background:

Traditional vaccines (killed/attenuated microorganisms) are effective but have safety concerns.
Subunit vaccines simplify formulations by using specific microbial components for targeted immunity.
This simplification can reduce immunogenicity, necessitating the use of adjuvants.

Purpose of the Study:

To review the current state and future directions in subunit vaccine development.
To highlight the role of molecular-level characterization and optimization in vaccine design.
To emphasize the importance of adjuvants and delivery systems in enhancing vaccine efficacy.

Main Methods:

Review of current literature on subunit vaccine development.
Analysis of strategies for immune response customization, including adjuvants, delivery systems, particle size, and cellular targeting.
Discussion of the potential of specific components like promiscuous T-helper epitopes.

Main Results:

Subunit vaccines allow for molecular characterization and improved safety profiles.
Adjuvant development is critical to overcome the reduced immunogenicity of subunit vaccines.
Optimization of delivery systems and other components can further tailor immune responses.

Conclusions:

Subunit vaccines represent a promising avenue for developing new vaccines against challenging diseases.
Adjuvants and advanced delivery systems are key areas for innovation in vaccine development.
Customizing vaccine components offers significant potential for steering immune responses effectively.